Srinivas Vourganti to Neoplasm Grading
This is a "connection" page, showing publications Srinivas Vourganti has written about Neoplasm Grading.
Connection Strength
0.128
-
Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
Score: 0.040
-
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol. 2014 May-Jun; 20(3):234-8.
Score: 0.031
-
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013 Nov; 64(5):713-719.
Score: 0.029
-
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol. 2013 Nov; 190(5):1721-1727.
Score: 0.029